but 95 plus percent of cancers are not arising from germline mutations they are arising from sematic mutations or acquired mutations
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
but 95 plus percent of cancers are not arising from germline mutations they are arising from sematic mutations or acquired mutations
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so question one is how much of cancer results from those types of genetic mutations and the answer is very little less than 5%
cancer is a genetic disease in the sense that every Cancer has genetic mutations um most of those mutations are sematic which means most of those mutations are mutations that occur during the course of our life they're not germline mutations the germline being the uh eggs and sperm right so it's all other cells
I mean I think everybody agrees that most cancers involve somatic mutations you know they're very few cancers that involve germline mutations that's those are the those are the exceptions but the the general one is these are required mutations
these aren't typically mutations that people are born with although in diseases like Lynch syndrome that might be the case that it leads to that but but for these are acquired mutations
cancer is a genetic disease in the sense that every cancer has genetic mutations um most of those mutations are sematic which means most of those mutations are mutations that occur during the course of our life they're not germline mutations the germline being the uh eggs and sperm right so it's all other cells
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.